These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 34194041)

  • 21. Safety, Immunogenicity, and Protective Efficacy of Intradermal Immunization with Aseptic, Purified, Cryopreserved Plasmodium falciparum Sporozoites in Volunteers Under Chloroquine Prophylaxis: A Randomized Controlled Trial.
    Bastiaens GJH; van Meer MPA; Scholzen A; Obiero JM; Vatanshenassan M; van Grinsven T; Sim BKL; Billingsley PF; James ER; Gunasekera A; Bijker EM; van Gemert GJ; van de Vegte-Bolmer M; Graumans W; Hermsen CC; de Mast Q; van der Ven AJAM; Hoffman SL; Sauerwein RW
    Am J Trop Med Hyg; 2016 Mar; 94(3):663-673. PubMed ID: 26711509
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dose-Dependent Infectivity of Aseptic, Purified, Cryopreserved Plasmodium falciparum 7G8 Sporozoites in Malaria-Naive Adults.
    Laurens MB; Berry AA; Travassos MA; Strauss K; Adams M; Shrestha B; Li T; Eappen A; Manoj A; Abebe Y; Murshedkar T; Gunasekera A; Richie TL; Lyke KE; Plowe CV; Kennedy JK; Potter GE; Deye GA; Sim BKL; Hoffman SL
    J Infect Dis; 2019 Nov; 220(12):1962-1966. PubMed ID: 31419294
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Safety, Immunogenicity, and Protective Efficacy against Controlled Human Malaria Infection of
    Jongo SA; Shekalaghe SA; Church LWP; Ruben AJ; Schindler T; Zenklusen I; Rutishauser T; Rothen J; Tumbo A; Mkindi C; Mpina M; Mtoro AT; Ishizuka AS; Kassim KR; Milando FA; Qassim M; Juma OA; Mwakasungula S; Simon B; James ER; Abebe Y; Kc N; Chakravarty S; Saverino E; Bakari BM; Billingsley PF; Seder RA; Daubenberger C; Sim BKL; Richie TL; Tanner M; Abdulla S; Hoffman SL
    Am J Trop Med Hyg; 2018 Aug; 99(2):338-349. PubMed ID: 29943719
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Protection against malaria by intravenous immunization with a nonreplicating sporozoite vaccine.
    Seder RA; Chang LJ; Enama ME; Zephir KL; Sarwar UN; Gordon IJ; Holman LA; James ER; Billingsley PF; Gunasekera A; Richman A; Chakravarty S; Manoj A; Velmurugan S; Li M; Ruben AJ; Li T; Eappen AG; Stafford RE; Plummer SH; Hendel CS; Novik L; Costner PJ; Mendoza FH; Saunders JG; Nason MC; Richardson JH; Murphy J; Davidson SA; Richie TL; Sedegah M; Sutamihardja A; Fahle GA; Lyke KE; Laurens MB; Roederer M; Tewari K; Epstein JE; Sim BK; Ledgerwood JE; Graham BS; Hoffman SL;
    Science; 2013 Sep; 341(6152):1359-65. PubMed ID: 23929949
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Multidose Priming and Delayed Boosting Improve Plasmodium falciparum Sporozoite Vaccine Efficacy Against Heterologous P. falciparum Controlled Human Malaria Infection.
    Lyke KE; Singer A; Berry AA; Reyes S; Chakravarty S; James ER; Billingsley PF; Gunasekera A; Manoj A; Murshedkar T; Laurens MB; Church WP; Garver Baldwin LS; Sedegah M; Banania G; Ganeshan H; Guzman I; Reyes A; Wong M; Belmonte A; Ozemoya A; Belmonte M; Huang J; Villasante E; Sim BKL; Hoffman SL; Richie TL; Epstein JE;
    Clin Infect Dis; 2021 Oct; 73(7):e2424-e2435. PubMed ID: 32920641
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Role of human Pegivirus infections in whole Plasmodium falciparum sporozoite vaccination and controlled human malaria infection in African volunteers.
    Tumbo AM; Schindler T; Dangy JP; Orlova-Fink N; Bieri JR; Mpina M; Milando FA; Juma O; Hamad A; Nyakarungu E; Chemba M; Mtoro A; Ramadhan K; Olotu A; Makweba D; Mgaya S; Stuart K; Perreau M; Stapleton JT; Jongo S; Hoffman SL; Tanner M; Abdulla S; Daubenberger C
    Virol J; 2021 Jan; 18(1):28. PubMed ID: 33499880
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A double-blind, placebo-controlled phase 1/2a trial of the genetically attenuated malaria vaccine PfSPZ-GA1.
    Roestenberg M; Walk J; van der Boor SC; Langenberg MCC; Hoogerwerf MA; Janse JJ; Manurung M; Yap XZ; García AF; Koopman JPR; Meij P; Wessels E; Teelen K; van Waardenburg YM; van de Vegte-Bolmer M; van Gemert GJ; Visser LG; van der Ven AJAM; de Mast Q; Natasha KC; Abebe Y; Murshedkar T; Billingsley PF; Richie TL; Sim BKL; Janse CJ; Hoffman SL; Khan SM; Sauerwein RW
    Sci Transl Med; 2020 May; 12(544):. PubMed ID: 32434847
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mosquito bite immunization with radiation-attenuated Plasmodium falciparum sporozoites: safety, tolerability, protective efficacy and humoral immunogenicity.
    Hickey BW; Lumsden JM; Reyes S; Sedegah M; Hollingdale MR; Freilich DA; Luke TC; Charoenvit Y; Goh LM; Berzins MP; Bebris L; Sacci JB; De La Vega P; Wang R; Ganeshan H; Abot EN; Carucci DJ; Doolan DL; Brice GT; Kumar A; Aguiar J; Nutman TB; Leitman SF; Hoffman SL; Epstein JE; Richie TL
    Malar J; 2016 Jul; 15(1):377. PubMed ID: 27448805
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A replication competent Plasmodium falciparum parasite completely attenuated by dual gene deletion.
    Goswami D; Patel H; Betz W; Armstrong J; Camargo N; Patil A; Chakravarty S; Murphy SC; Sim BKL; Vaughan AM; Hoffman SL; Kappe SH
    EMBO Mol Med; 2024 Apr; 16(4):723-754. PubMed ID: 38514791
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Controlled human malaria infection by intramuscular and direct venous inoculation of cryopreserved Plasmodium falciparum sporozoites in malaria-naïve volunteers: effect of injection volume and dose on infectivity rates.
    Gómez-Pérez GP; Legarda A; Muñoz J; Sim BK; Ballester MR; Dobaño C; Moncunill G; Campo JJ; Cisteró P; Jimenez A; Barrios D; Mordmüller B; Pardos J; Navarro M; Zita CJ; Nhamuave CA; García-Basteiro AL; Sanz A; Aldea M; Manoj A; Gunasekera A; Billingsley PF; Aponte JJ; James ER; Guinovart C; Antonijoan RM; Kremsner PG; Hoffman SL; Alonso PL
    Malar J; 2015 Aug; 14():306. PubMed ID: 26245196
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Chemoprophylaxis Vaccination: Phase I Study to Explore Stage-specific Immunity to Plasmodium falciparum in US Adults.
    Healy SA; Murphy SC; Hume JCC; Shelton L; Kuntz S; Van Voorhis WC; Moodie Z; Metch B; Wang R; Silver-Brace T; Fishbaugher M; Kennedy M; Finney OC; Chaturvedi R; Marcsisin SR; Hobbs CV; Warner-Lubin M; Talley AK; Wong-Madden S; Stuart K; Wald A; Kappe SH; Kublin JG; Duffy PE
    Clin Infect Dis; 2020 Sep; 71(6):1481-1490. PubMed ID: 31621832
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Machine learning prediction of malaria vaccine efficacy based on antibody profiles.
    Wistuba-Hamprecht J; Reuter B; Fendel R; Hoffman SL; Campo JJ; Felgner PL; Kremsner PG; Mordmüller B; Pfeifer N
    PLoS Comput Biol; 2024 Jun; 20(6):e1012131. PubMed ID: 38848436
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Quantification of Plasmodium knowlesi versus Plasmodium falciparum in the rhesus liver: implications for malaria vaccine studies in rhesus models.
    Shears MJ; Seilie AM; Kim Lee Sim B; Hoffman SL; Murphy SC
    Malar J; 2020 Aug; 19(1):313. PubMed ID: 32867784
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Direct venous inoculation of Plasmodium falciparum sporozoites for controlled human malaria infection: a dose-finding trial in two centres.
    Mordmüller B; Supan C; Sim KL; Gómez-Pérez GP; Ospina Salazar CL; Held J; Bolte S; Esen M; Tschan S; Joanny F; Lamsfus Calle C; Löhr SJ; Lalremruata A; Gunasekera A; James ER; Billingsley PF; Richman A; Chakravarty S; Legarda A; Muñoz J; Antonijoan RM; Ballester MR; Hoffman SL; Alonso PL; Kremsner PG
    Malar J; 2015 Mar; 14():117. PubMed ID: 25889522
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A PfSPZ vaccine immunization regimen equally protective against homologous and heterologous controlled human malaria infection.
    Mordmüller B; Sulyok Z; Sulyok M; Molnar Z; Lalremruata A; Calle CL; Bayon PG; Esen M; Gmeiner M; Held J; Heimann HL; Woldearegai TG; Ibáñez J; Flügge J; Fendel R; Kreidenweiss A; Kc N; Murshedkar T; Chakravarty S; Riyahi P; Billingsley PF; Church LWP; Richie TL; Sim BKL; Hoffman SL; Kremsner PG
    NPJ Vaccines; 2022 Aug; 7(1):100. PubMed ID: 35999221
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Live attenuated malaria vaccine designed to protect through hepatic CD8⁺ T cell immunity.
    Epstein JE; Tewari K; Lyke KE; Sim BK; Billingsley PF; Laurens MB; Gunasekera A; Chakravarty S; James ER; Sedegah M; Richman A; Velmurugan S; Reyes S; Li M; Tucker K; Ahumada A; Ruben AJ; Li T; Stafford R; Eappen AG; Tamminga C; Bennett JW; Ockenhouse CF; Murphy JR; Komisar J; Thomas N; Loyevsky M; Birkett A; Plowe CV; Loucq C; Edelman R; Richie TL; Seder RA; Hoffman SL
    Science; 2011 Oct; 334(6055):475-80. PubMed ID: 21903775
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Safety and protective efficacy of PfSPZ Vaccine administered to HIV-negative and -positive Tanzanian adults.
    Jongo S; Church LWP; Milando F; Qassim M; Schindler T; Rashid M; Tumbo A; Nyaulingo G; Bakari BM; Athuman Mbaga T; Mohamed L; Kassimu K; Simon BS; Mpina M; Zaidi I; Duffy PE; Swanson PA; Seder R; Herman JD; Mendu M; Zur Y; Alter G; Kc N; Riyahi P; Abebe Y; Murshedkar T; James ER; Billingsley PF; Sim BKL; Richie TL; Daubenberger C; Abdulla S; Hoffman SL
    J Clin Invest; 2024 Jan; 134(6):. PubMed ID: 38194272
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Increase of Dose Associated With Decrease in Protection Against Controlled Human Malaria Infection by PfSPZ Vaccine in Tanzanian Adults.
    Jongo SA; Church LWP; Mtoro AT; Schindler T; Chakravarty S; Ruben AJ; Swanson PA; Kassim KR; Mpina M; Tumbo AM; Milando FA; Qassim M; Juma OA; Bakari BM; Simon B; James ER; Abebe Y; Kc N; Saverino E; Fink M; Cosi G; Gondwe L; Studer F; Styers D; Seder RA; Schindler T; Billingsley PF; Daubenberger C; Sim BKL; Tanner M; Richie TL; Abdulla S; Hoffman SL
    Clin Infect Dis; 2020 Dec; 71(11):2849-2857. PubMed ID: 31782768
    [TBL] [Abstract][Full Text] [Related]  

  • 39. IMRAS-A clinical trial of mosquito-bite immunization with live, radiation-attenuated P. falciparum sporozoites: Impact of immunization parameters on protective efficacy and generation of a repository of immunologic reagents.
    Hickey B; Teneza-Mora N; Lumsden J; Reyes S; Sedegah M; Garver L; Hollingdale MR; Banania JG; Ganeshan H; Dowler M; Reyes A; Tamminga C; Singer A; Simmons A; Belmonte M; Belmonte A; Huang J; Inoue S; Velasco R; Abot S; Vasquez CS; Guzman I; Wong M; Twomey P; Wojnarski M; Moon J; Alcorta Y; Maiolatesi S; Spring M; Davidson S; Chaudhury S; Villasante E; Richie TL; Epstein JE
    PLoS One; 2020; 15(6):e0233840. PubMed ID: 32555601
    [TBL] [Abstract][Full Text] [Related]  

  • 40. DSM265 for Plasmodium falciparum chemoprophylaxis: a randomised, double blinded, phase 1 trial with controlled human malaria infection.
    Sulyok M; Rückle T; Roth A; Mürbeth RE; Chalon S; Kerr N; Samec SS; Gobeau N; Calle CL; Ibáñez J; Sulyok Z; Held J; Gebru T; Granados P; Brückner S; Nguetse C; Mengue J; Lalremruata A; Sim BKL; Hoffman SL; Möhrle JJ; Kremsner PG; Mordmüller B
    Lancet Infect Dis; 2017 Jun; 17(6):636-644. PubMed ID: 28363637
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.